Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v18-FR Version v5-FR
Language French French
Date Updated 2020-09-24 2019-04-22
Drug Identification Number 02426544 02426544
Brand name FLUMIST QUADRIVALENT FLUMIST QUADRIVALENT
Common or Proper name Influenza vaccine (live, attenuated) Influenza vaccine (live, attenuated)
Company Name ASTRAZENECA CANADA INC ASTRAZENECA CANADA INC
Ingredients Influenza Virus Type A Influenza Virus Type A Influenza virus type B Influenza virus type B Influenza Virus Type A Influenza Virus Type A Influenza virus type B Influenza virus type B
Strength(s) 32000000FFU 32000000FFU 32000000FFU 32000000FFU 32000000FFU 32000000FFU 32000000FFU 32000000FFU
Dosage form(s) SPRAY SPRAY
Route of administration NASAL NASAL
Packaging size 10 single use pre-filled syringes 10 single use pre-filled syringes
ATC code J07BB J07BB
ATC description VIRAL VACCINES VIRAL VACCINES
Reason for shortage Shortage of an active ingredient. Shortage of an active ingredient.
Anticipated start date 2019-10-01 2019-10-01
Actual start date 2019-10-01
Estimated end date 2020-09-23 Unknown
Actual end date 2020-09-23
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Influenza vaccine for 2020-2021 season estimated availability September 23, 2020, in limited quantities Influenza vaccine for 2019-2020 season
Health Canada comments